251 related articles for article (PubMed ID: 16101412)
1. Vitamin D receptor modulators for inflammation and cancer.
Yee YK; Chintalacharuvu SR; Lu J; Nagpal S
Mini Rev Med Chem; 2005 Aug; 5(8):761-78. PubMed ID: 16101412
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor as a drug discovery target.
Pinette KV; Yee YK; Amegadzie BY; Nagpal S
Mini Rev Med Chem; 2003 May; 3(3):193-204. PubMed ID: 12570835
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
4. [Current Topics on Vitamin D. Nonsecosteroidal vitamin D mudulators and prospects for their thepapeutic application].
Makishima M
Clin Calcium; 2015 Mar; 25(3):403-11. PubMed ID: 25716814
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor ligands for osteoporosis.
Cheskis BJ; Freedman LP; Nagpal S
Curr Opin Investig Drugs; 2006 Oct; 7(10):906-11. PubMed ID: 17086935
[TBL] [Abstract][Full Text] [Related]
6. Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases.
Vertino AM; Bula CM; Chen JR; Almeida M; Han L; Bellido T; Kousteni S; Norman AW; Manolagas SC
J Biol Chem; 2005 Apr; 280(14):14130-7. PubMed ID: 15671029
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor 2016: novel ligands and structural insights.
Maestro MA; Molnár F; Mouriño A; Carlberg C
Expert Opin Ther Pat; 2016 Nov; 26(11):1291-1306. PubMed ID: 27454349
[TBL] [Abstract][Full Text] [Related]
8. Structural Studies of Vitamin D Nuclear Receptor Ligand-Binding Properties.
Belorusova AY; Rochel N
Vitam Horm; 2016; 100():83-116. PubMed ID: 26827949
[TBL] [Abstract][Full Text] [Related]
9. Minireview: vitamin D receptor: new assignments for an already busy receptor.
Norman AW
Endocrinology; 2006 Dec; 147(12):5542-8. PubMed ID: 16946007
[TBL] [Abstract][Full Text] [Related]
10. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
11. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators.
Ma Y; Khalifa B; Yee YK; Lu J; Memezawa A; Savkur RS; Yamamoto Y; Chintalacharuvu SR; Yamaoka K; Stayrook KR; Bramlett KS; Zeng QQ; Chandrasekhar S; Yu XP; Linebarger JH; Iturria SJ; Burris TP; Kato S; Chin WW; Nagpal S
J Clin Invest; 2006 Apr; 116(4):892-904. PubMed ID: 16528410
[TBL] [Abstract][Full Text] [Related]
13. [Update on recent progress in vitamin D research. Vitamin D receptor and the nuclear receptor superfamily.].
Makishima M
Clin Calcium; 2017; 27(11):1533-1541. PubMed ID: 29074825
[TBL] [Abstract][Full Text] [Related]
14. Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3.
Christakos S; Raval-Pandya M; Wernyj RP; Yang W
Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):361-71. PubMed ID: 8687373
[TBL] [Abstract][Full Text] [Related]
15. The 1,25(OH)2D3-regulated transcription factor MN1 stimulates vitamin D receptor-mediated transcription and inhibits osteoblastic cell proliferation.
Sutton AL; Zhang X; Ellison TI; Macdonald PN
Mol Endocrinol; 2005 Sep; 19(9):2234-44. PubMed ID: 15890672
[TBL] [Abstract][Full Text] [Related]
16. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
[TBL] [Abstract][Full Text] [Related]
17. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
18. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system.
Zhao XY; Eccleshall TR; Krishnan AV; Gross C; Feldman D
Mol Endocrinol; 1997 Mar; 11(3):366-78. PubMed ID: 9058382
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D analogs: mechanism of action and therapeutic applications.
Nagpal S; Lu J; Boehm MF
Curr Med Chem; 2001 Nov; 8(13):1661-79. PubMed ID: 11562285
[TBL] [Abstract][Full Text] [Related]
20. Control of Inflammatory Bowel Disease and Colorectal Cancer by Synthetic Vitamin D Receptor Ligands.
Takada I; Makishima M
Curr Med Chem; 2017; 24(9):868-875. PubMed ID: 27915991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
